Pharmaceuticals

Infosys wins multi-million dollar AstraZeneca deal

15 Dec 2008

Pharmaceutical companies asked to pass excise benefits to consumers

15 Dec 2008

Pharma sector attracts Atlas Cycles and Shanku Group

06 Dec 2008

Research proves branded drugs not superior to generics

05 Dec 2008

Researchers debunk the myth that branded drugs are superior to generics for treating cardiovascular diseases

Wockhardt gets US FDA approval for paediatrics drug

04 Dec 2008

Ranbaxy in pact to market BioPro's brain tumour drug in India

03 Dec 2008

J&J buys breast implant maker Mentor Corp for $1.07 billion

01 Dec 2008

Plethico to take 20 per cent stake in CIS drug maker

29 Nov 2008

Drug firms misusing patents to block cheaper generics: EU

28 Nov 2008

Sun Pharma's US arm acquires Chattem

27 Nov 2008

AstraZeneca, Abraxis rethink cancer drug deal

26 Nov 2008

Sanofi settles Allegra, Nasacort patent suits with Teva, Barr

20 Nov 2008

AstraZeneca agrees to cut drug prices in UK, stock plummets

20 Nov 2008

Glenmark launches `Azathioprine' tablets in US

20 Nov 2008

Teva in bid to make generic version of Gilead's AIDS drug Truvada

15 Nov 2008

Wockhardt gets USFDA approval for insomnia drug sale

14 Nov 2008

US FDA observations not to affect drug sales: Lupin

14 Nov 2008

Daiichi Sankyo completes Ranbaxy acquisition

07 Nov 2008

Pfizer ends testing obesity drug on account of risk of US non-approval

06 Nov 2008

Sanofi's anti-obesity drug Acomplia pulled out of EU

25 Oct 2008

The European Medicines Evaluation Agency has suspended Sanofi-Aventis's anti-obesity drug Acomplia,  which is said to have been linked to  depression and suicide risks

Roche confirms plans to acquire remaining 44 per cent in Genentech

21 Oct 2008

Daiichi acquires 52.5 per cent in Ranbaxy

20 Oct 2008

CNBC-TV18 shares with domain-b its exclusive interview with Ranbaxy, CEO, Malvinder Singh

Cadila gets USFDA approval antyi-depressant Risperidone

20 Oct 2008

Ranbaxy-Daiichi deal hits a regulatory bump

17 Oct 2008

Wockhardt gets US FDA nod to market Ceftazidime injections

16 Oct 2008